Recent Finacing
Recent Raise
Ocugen is a biopharmaceutical company developing novel biologics and repurposed 505(b)(2) candidates for sight‑threatening retinal and corneal diseases, including programs for retinitis pigmentosa, wet AMD, and oGVHD.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors